Researchers are excited about new treatments for hepatitis

Researchers are excited about new treatments for hepatitis...especially the chronic, active forms of hepatitis B and C.

Antivirals are being tried...ribavirin for chronic hepatitis C and the new HIV drug, lamivudine (3TC), for chronic hepatitis B.

But no antivirals are approved for hepatitis...because their clinical benefit hasn't been shown. The ribavirin being studied for hepatitis is an ORAL form...not the aerosol version used for RSV.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote